Verified recordBiotechnology Research

Christopher Moen

Director, National Accounts at Pharmaessentia

Based in Minneapolis, United States

View on LinkedIn

7-day free trial · no credit card

Seniority

Director

Department

Sales & Business Development

Location

Minneapolis

Industry

Biotechnology Research

Company size

338

Contact information

Reveal Christopher's email and phone

Direct contact data is gated. Sign up and reveal. You only pay for verified records.

Email

1 credit

c•••••••@pharmaessentia.com

Phone

5 credits

+1 ••• •••• ••••

You only pay for valid records. Bounced emails and disconnected numbers cost nothing.

Background

About Christopher Moen

Managed Market & Payer Executive adept at cultivating profitable partnerships with key clientele and stakeholders to close high-stakes deals and expand product portfolios throughout the pharmaceutical ecosystem. Extensive experience directing complex change implementations and managing multidisciplinary teams to drive revenue growth and expand market share on a national scale, successfully positioning organizations as robust industry competitors. Results-oriented market access leader with a proven record of devising turnaround strategies to streamline processes and transform team members into million-dollar revenue generators. Areas of Expertise: Managed Markets Payer Strategy & Management Relationship Building Revenue Generation & Growth Senior Team Leadership Channel Strategy Trend Analysis & Forecasts Procurement Strategy Change Implementation Strategy Alignment Public Speaking Turnaround Strategy Select Accomplishments: • Led Quarterly Business Reviews (QBRs) with Channel Partners, communicating key performance indicators (KPIs) of distributor and pharmacies to both internal and external stakeholders in order to effectively safeguard partner performance, gap identification, and timely issue resolution. • Managed all procurement of pharmaceuticals equating to over $400M generics and $3B brand annually, providing comprehensive directions to two mail order sites and one specialty pharmacy to ensure efficiency and accuracy in all operations. • Successfully pioneered the Omnitrope exclusive agreement negotiation in 2008, ultimately delivering major savings to clients for an essential pharmaceutical. • Upheld market perception of the drug and therapeutics class by strategically maintaining and increasing access to Opsumit after generic competition entered the market in the PAH drug class.

Decision-makers

Other people at Pharmaessentia

Browse the Pharmaessentia team →

Build a list of verified contacts at Pharmaessentia

Free for 7 days · 50 credits · no card · only pay for verified records.

Start free

Reach more buyers like Christopher

250M+ professionals with verified email and phone. You only pay for records that actually verify.

7-day trial · no credit card · cancel anytime

Christopher Moen Email & Phone Number @ Pharmaessentia | Kipplo Discover